Top Quality Chemical Rivaroxaban Intermediate Powder Rivaroxaban

• Customization: Available
• CAS No.: 366789-02-8
• Formula: C19h18cln3o5s
• Model NO.: QS-Rivaroxaban
• Packaging Material: Negotiable
• Storage Method: Normal
• Shelf Life: 2 Years
• Nutrient Composition: Rivaroxaban
• Resource: Rivaroxaban
• The content of active substances: 99%
• Product Name: Rivaroxaban
• Name: Rivaroxaban Powder
• Density: 1.46
• Mf: C19h18cln3o5s
• Melting Point: 228-229
• Appearance: White Powder
• Color: White
• Store: Cool and Dry
• Grade: Pharmaceutical Grade
• Assay: HPLC 99%
• Application: Anthelmintics
• Specific: COA
• Test Method: HPLC
• Solubility: in Water, 25.05 Mg/L at 25 °c (Est)
• Pka: 13.36±0.46(Predicted)
• Transport Package: Negotiable
• Specification: 99%
• Trademark: QS
• Origin: Xi′an Shaanxi
• Production Capacity: 500kg/Month

Product Description

Top Quality Chemical Rivaroxaban Intermediate Powder Rivaroxaban

Prouct Description

Product Details

Product Name	Rivaroxaban
Apperance	White Powder
CAS	366789-02-8
MF	C19H18ClN3O5S
MW	435.89

Rivaroxaban can be simply understood as an "antithrombotic drug" or "anticoagulant", and is suitable for various situations where thrombosis needs to be prevented, such as after some surgeries and the prevention and treatment of cardiovascular and cerebrovascular diseases. Specifically, rivaroxaban is a selective inhibitor of factor Xa (FXa), which has no direct effect on platelet aggregation but indirectly inhibits platelet aggregation induced by thrombin. Rivaroxaban achieves the effect of preventing or reducing thrombosis by inhibiting FXa and reducing the production of thrombin. Rivaroxaban is a prescription drug and can only be dispensed, purchased and used with a prescription.

Application&Function

 

Description
Rivaroxaban is mainly a drug for treating venous thrombosis in adults.
Purpose
It is used for adult patients undergoing elective hip or knee replacement surgery to prevent venous thrombosis (VTE).
Rivaroxaban is an efficient selective Factor Xa (FXa) inhibitor with strong anti-FXA activity (IC50 is 0.7 nM, Ki is 0.4 nM).

Specification

 

 

 

 

ABOUT US